Ignite Creation Date:
2025-12-26 @ 12:17 PM
Ignite Modification Date:
2025-12-26 @ 12:17 PM
Study NCT ID:
NCT00698100
Status:
COMPLETED
Last Update Posted:
2011-09-16
First Post:
2008-06-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-06
Start Date Type:
None
Primary Completion Date:
2011-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-12
First Submit QC Date:
None
Study First Post Date:
2008-06-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-09-15
Last Update Post Date:
2011-09-16
Last Update Post Date Type:
ESTIMATED